In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Completed strategic review to focus on oncology and liver diseases with the acquisition of global rights to GB3226 (formerly BRM-1420), a dual ENL-YEATS and FLT3 inhibitor for multiple genetic subsets ...

A leading hay fever expert says the majority of sufferers don't seek help or know how to treat it properly, but a new trial ...

With limited access to mental health care, people looking for answers about ADHD are turning to TikTok, where information is frequently misleading or inaccurate ...

Karen Winkfield, MD, PhD, addresses the importance of meeting patients where they are to expand clinical trial participation ...

An overwhelming majority of Australians struggling with their mental health are turning to social media – not trained ...

Net research and development expenses for the device division increased in 2024 to CAD175,000 from CAD44,000 in 2023, a 400% increase. The increase is attributed to development of a new software ...

InformedDNA®, a precision health company revolutionizing the application of genomic insights, today announced the acquisition of Coriell Life Sciences, a provider of pharmacogenomic services and ...

Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers ...

The University of Rochester Wilmot Cancer Institute received a national designation. This is how it will improve access to ...

Interest in clinical trials is high, but barriers like cost and lack of doctor communication hinder participation. Survey shows patient eagerness.

The National Comprehensive Cancer Network® (NCCN®) has released a free, on-demand webinar titled “Why Should I Consider a ...